vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and Baird Medical Investment Holdings Ltd (BDMD). Click either name above to swap in a different company.

BayFirst Financial Corp. is the larger business by last-quarter revenue ($11.2M vs $8.0M, roughly 1.4× Baird Medical Investment Holdings Ltd). BayFirst Financial Corp. runs the higher net margin — -22.1% vs -142.7%, a 120.6% gap on every dollar of revenue. BayFirst Financial Corp. produced more free cash flow last quarter ($285.0M vs $-3.2M).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

BAFN vs BDMD — Head-to-Head

Bigger by revenue
BAFN
BAFN
1.4× larger
BAFN
$11.2M
$8.0M
BDMD
Higher net margin
BAFN
BAFN
120.6% more per $
BAFN
-22.1%
-142.7%
BDMD
More free cash flow
BAFN
BAFN
$288.2M more FCF
BAFN
$285.0M
$-3.2M
BDMD

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
BAFN
BAFN
BDMD
BDMD
Revenue
$11.2M
$8.0M
Net Profit
$-2.5M
$-11.4M
Gross Margin
82.1%
Operating Margin
-25.3%
-131.3%
Net Margin
-22.1%
-142.7%
Revenue YoY
4.7%
Net Profit YoY
-125.2%
EPS (diluted)
$-0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
BDMD
BDMD
Q4 25
$11.2M
Q3 25
$10.2M
Q2 25
$23.1M
$8.0M
Q1 25
$19.8M
Q4 24
$32.9M
Q3 24
$21.7M
Q2 24
$20.8M
Q1 24
$23.0M
Net Profit
BAFN
BAFN
BDMD
BDMD
Q4 25
$-2.5M
Q3 25
$-18.9M
Q2 25
$-1.2M
$-11.4M
Q1 25
$-335.0K
Q4 24
$9.8M
Q3 24
$1.1M
Q2 24
$866.0K
Q1 24
$824.0K
Gross Margin
BAFN
BAFN
BDMD
BDMD
Q4 25
Q3 25
Q2 25
82.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BAFN
BAFN
BDMD
BDMD
Q4 25
-25.3%
Q3 25
-253.0%
Q2 25
-7.1%
-131.3%
Q1 25
-2.3%
Q4 24
Q3 24
7.1%
Q2 24
5.9%
Q1 24
5.1%
Net Margin
BAFN
BAFN
BDMD
BDMD
Q4 25
-22.1%
Q3 25
-184.7%
Q2 25
-5.3%
-142.7%
Q1 25
-1.7%
Q4 24
91.8%
Q3 24
5.2%
Q2 24
4.2%
Q1 24
3.6%
EPS (diluted)
BAFN
BAFN
BDMD
BDMD
Q4 25
$-0.71
Q3 25
$-4.66
Q2 25
$-0.39
Q1 25
$-0.17
Q4 24
$2.21
Q3 24
$0.18
Q2 24
$0.12
Q1 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
BDMD
BDMD
Cash + ST InvestmentsLiquidity on hand
$207.0M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$87.6M
$35.6M
Total Assets
$1.3B
$77.0M
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
BDMD
BDMD
Q4 25
$207.0M
Q3 25
$118.5M
Q2 25
$77.3M
Q1 25
$63.2M
Q4 24
$77.8M
Q3 24
$64.4M
Q2 24
$60.8M
Q1 24
$57.5M
Total Debt
BAFN
BAFN
BDMD
BDMD
Q4 25
Q3 25
Q2 25
$8.4M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BAFN
BAFN
BDMD
BDMD
Q4 25
$87.6M
Q3 25
$89.7M
Q2 25
$108.2M
$35.6M
Q1 25
$110.1M
Q4 24
$110.9M
Q3 24
$102.3M
Q2 24
$101.0M
Q1 24
$100.6M
Total Assets
BAFN
BAFN
BDMD
BDMD
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
$1.3B
$77.0M
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.1B
Debt / Equity
BAFN
BAFN
BDMD
BDMD
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
BDMD
BDMD
Operating Cash FlowLast quarter
$285.3M
$-3.2M
Free Cash FlowOCF − Capex
$285.0M
$-3.2M
FCF MarginFCF / Revenue
2554.2%
-40.7%
Capex IntensityCapex / Revenue
2.7%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$469.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
BDMD
BDMD
Q4 25
$285.3M
Q3 25
$47.3M
Q2 25
$63.3M
$-3.2M
Q1 25
$74.2M
Q4 24
$390.5M
Q3 24
$90.8M
Q2 24
$78.8M
Q1 24
$123.5M
Free Cash Flow
BAFN
BAFN
BDMD
BDMD
Q4 25
$285.0M
Q3 25
$47.3M
Q2 25
$63.1M
$-3.2M
Q1 25
$74.1M
Q4 24
$388.8M
Q3 24
$90.5M
Q2 24
$78.4M
Q1 24
$122.5M
FCF Margin
BAFN
BAFN
BDMD
BDMD
Q4 25
2554.2%
Q3 25
462.2%
Q2 25
272.7%
-40.7%
Q1 25
375.1%
Q4 24
1180.9%
Q3 24
416.5%
Q2 24
376.1%
Q1 24
532.5%
Capex Intensity
BAFN
BAFN
BDMD
BDMD
Q4 25
2.7%
Q3 25
0.1%
Q2 25
0.8%
0.6%
Q1 25
0.4%
Q4 24
5.1%
Q3 24
1.5%
Q2 24
1.9%
Q1 24
4.4%
Cash Conversion
BAFN
BAFN
BDMD
BDMD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.95×
Q3 24
79.85×
Q2 24
90.94×
Q1 24
149.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons